• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

SHPG:US

252.6700 USD 0.2700 0.11%

As of 20:10:00 ET on 07/25/2014.

Snapshot for Shire PLC (SHPG)

Open: 254.3200 Day's Range: 252.0800 - 254.7400 Volume: 1,173,363
Previous Close: 252.9400 52wk Range: 109.2100 - 258.5500 1-Yr Rtn: +133.57%

Stock Chart for SHPG

No chart data available.
  • SHPG:US 252.6700
  • 1D
  • 1M
  • 1Y
252.9400
Interactive SHPG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SHPG

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 25.8618
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 9.7700
Est. PEG Ratio 2.0241
Market Cap (M USD) 49,651.12
Shares Outstanding (M) 196.51
30 Day Average Volume 2,150,896
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.40%
Cash Dividend (USD) 0.5079
Dividend Ex-Date 03/05/2014
5 Year Dividend Growth 15.00%
Next Earnings Announcement 10/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SHPG

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SHPG

Shire PLC markets, licenses and develops prescription medicines. The Group focuses its operations on attention deficit and hyperactivity disorders, human genetic therapies, gastrointestinal, and renal diseases.

Flemming OrnskovChief Executive OfficerJames BowlingInterim CFO/Senior VP/Controller
Tatjana MaySecretary/General CounselJeff PoultonHead:Investor Relations
More Company Profile & Key Executives for SHPG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil